News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
711,491 Results
Type
Article (40399)
Company Profile (261)
Press Release (670820)
Multimedia
Podcasts (70)
Webinars (16)
Section
Business (204460)
Career Advice (2015)
Deals (35476)
Drug Delivery (99)
Drug Development (81231)
Employer Resources (173)
FDA (16307)
Job Trends (14914)
News (345885)
Policy (32682)
Tag
Academia (2557)
Accelerated approval (15)
Adcomms (24)
Allergies (113)
Alliances (49573)
ALS (131)
Alzheimer's disease (1545)
Antibody-drug conjugate (ADC) (186)
Approvals (16384)
Artificial intelligence (375)
Autoimmune disease (58)
Automation (25)
Bankruptcy (361)
Best Places to Work (11636)
BIOSECURE Act (20)
Biosimilars (144)
Biotechnology (175)
Bladder cancer (116)
Brain cancer (44)
Breast cancer (448)
Cancer (3522)
Cardiovascular disease (288)
Career advice (1691)
Career pathing (33)
CAR-T (215)
CDC (42)
Cell therapy (582)
Cervical cancer (30)
Clinical research (67761)
Collaboration (1243)
Company closure (4)
Compensation (899)
Complete response letters (42)
COVID-19 (2668)
CRISPR (70)
C-suite (521)
Cystic fibrosis (122)
Data (4111)
Decentralized trials (2)
Denatured (22)
Depression (90)
Diabetes (405)
Diagnostics (6519)
Digital health (32)
Diversity (10)
Diversity, equity & inclusion (45)
Drug discovery (174)
Drug pricing (150)
Drug shortages (28)
Duchenne muscular dystrophy (187)
Earnings (88630)
Editorial (45)
Employer branding (21)
Employer resources (150)
Events (114946)
Executive appointments (908)
FDA (18596)
Fibrodysplasia Ossificans Progressiva (3)
Friedreich's ataxia (5)
Frontotemporal dementia (13)
Funding (1126)
Gene editing (155)
Generative AI (26)
Gene therapy (464)
GLP-1 (850)
Government (4592)
Grass and pollen (5)
Guidances (333)
Healthcare (18854)
HIV (42)
Huntington's disease (34)
IgA nephropathy (50)
Immunology and inflammation (197)
Immuno-oncology (14)
Indications (51)
Infectious disease (2874)
Inflammatory bowel disease (166)
Inflation Reduction Act (12)
Influenza (83)
Intellectual property (176)
Interviews (314)
IPO (16607)
IRA (48)
Job creations (3639)
Job search strategy (1425)
Kidney cancer (13)
Labor market (67)
Layoffs (530)
Leadership (23)
Legal (7937)
Liver cancer (84)
Longevity (11)
Lung cancer (504)
Lymphoma (250)
Machine learning (27)
Management (59)
Manufacturing (557)
MASH (125)
Medical device (13583)
Medtech (13602)
Mergers & acquisitions (19714)
Metabolic disorders (998)
Multiple sclerosis (130)
NASH (16)
Neurodegenerative disease (190)
Neuropsychiatric disorders (46)
Neuroscience (2463)
NextGen: Class of 2025 (6516)
Non-profit (4492)
Now hiring (56)
Obesity (473)
Opinion (235)
Ovarian cancer (120)
Pain (142)
Pancreatic cancer (159)
Parkinson's disease (221)
Partnered (27)
Patents (386)
Patient recruitment (284)
Peanut (52)
People (58137)
Pharmaceutical (63)
Pharmacy benefit managers (23)
Phase I (21089)
Phase II (29847)
Phase III (22196)
Pipeline (2569)
Policy (240)
Postmarket research (2564)
Preclinical (8984)
Press Release (64)
Prostate cancer (179)
Psychedelics (41)
Radiopharmaceuticals (256)
Rare diseases (564)
Real estate (5935)
Recruiting (68)
Regulatory (23326)
Reports (51)
Research institute (2347)
Resumes & cover letters (350)
Rett syndrome (14)
RNA editing (11)
RSV (61)
Schizophrenia (119)
Series A (185)
Series B (139)
Service/supplier (11)
Sickle cell disease (72)
Special edition (20)
Spinal muscular atrophy (149)
Sponsored (34)
Startups (3599)
State (2)
Stomach cancer (14)
Supply chain (91)
Tariffs (78)
The Weekly (46)
Vaccines (884)
Venture capital (62)
Weight loss (304)
Women's health (53)
Worklife (17)
Date
Today (68)
Last 7 days (510)
Last 30 days (2105)
Last 365 days (30541)
2025 (23388)
2024 (35216)
2023 (40077)
2022 (51174)
2021 (55710)
2020 (54083)
2019 (46538)
2018 (35018)
2017 (32108)
2016 (31480)
2015 (37552)
2014 (31320)
2013 (26345)
2012 (28570)
2011 (29263)
2010 (27328)
Location
Africa (726)
Alabama (71)
Alaska (7)
Arizona (265)
Arkansas (13)
Asia (38557)
Australia (6299)
California (8900)
Canada (2753)
China (804)
Colorado (376)
Connecticut (379)
Delaware (242)
Europe (83058)
Florida (1328)
Georgia (292)
Hawaii (2)
Idaho (60)
Illinois (695)
India (43)
Indiana (424)
Iowa (17)
Japan (298)
Kansas (116)
Kentucky (33)
Louisiana (16)
Maine (67)
Maryland (1174)
Massachusetts (6501)
Michigan (274)
Minnesota (520)
Mississippi (4)
Missouri (105)
Montana (29)
Nebraska (25)
Nevada (101)
New Hampshire (68)
New Jersey (2437)
New Mexico (28)
New York (2427)
North Carolina (1228)
North Dakota (8)
Northern California (4084)
Ohio (272)
Oklahoma (19)
Oregon (36)
Pennsylvania (1875)
Puerto Rico (18)
Rhode Island (43)
South America (1100)
South Carolina (44)
South Dakota (1)
Southern California (3428)
Tennessee (145)
Texas (1371)
United States (32340)
Utah (261)
Virginia (216)
Washington D.C. (76)
Washington State (744)
West Virginia (4)
Wisconsin (76)
Wyoming (1)
711,491 Results for "nurix inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Nurix Therapeutics Reports Third Quarter 2025 Financial Results and Provides a Corporate Update
October 9, 2025
·
13 min read
Press Releases
Nurix Therapeutics to Participate in Upcoming September 2025 Investor Conferences
August 29, 2025
·
2 min read
Press Releases
Sanofi Exercises License Extension Option to Nurix’s STAT6 Program
June 2, 2025
·
7 min read
Press Releases
Nurix Therapeutics Presents Preclinical Data from Novel IRAK4 Degrader, GS-6791, Demonstrating Potent Inhibition of IL-1 and IL-36 in Vitro and Efficacy in a Model of Dermatitis
September 18, 2025
·
8 min read
Press Releases
Nurix Therapeutics Reports Second Quarter 2025 Financial Results and Provides a Corporate Update
July 9, 2025
·
15 min read
Press Releases
Nurix Therapeutics to Participate in the Jefferies Global Healthcare Conference
May 28, 2025
·
2 min read
Press Releases
Nurix Therapeutics to Participate in the RBC Capital Markets Global Healthcare Conference
May 15, 2025
·
2 min read
Press Releases
Nurix Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - June 13, 2025
June 16, 2025
·
3 min read
Biotech Bay
Nurix Therapeutics to Participate in the 2024 Jefferies Global Healthcare Conference
Nurix Therapeutics, Inc. announced that Arthur T. Sands, M.D., Ph.D., president and chief executive officer of Nurix, will present a corporate update at the Jefferies Global Healthcare Conference, at 5:30 p.m. ET on Wednesday, June 5, 2024, in New York City.
May 29, 2024
·
1 min read
Press Releases
Nurix Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) to thirteen new employees
May 16, 2025
·
3 min read
1 of 71,150
Next
